Prion Disease and the Innate Immune System
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Prion diseases or transmissible spongiform encephalopathies are a unique category of infectious protein-misfolding neurodegenerative disorders. Hypothesized to be caused by misfolding of the cellular prion protein these disorders possess an infectious quality that thrives in immune-competent hosts. While much has been discovered about the routing and critical components involved in the peripheral pathogenesis of these agents there are still many aspects to be discovered. Research into this area has been extensive as it represents a major target for therapeutic intervention within this group of diseases. The main focus of pathological damage in these diseases occurs within the central nervous system. Cells of the innate immune system have been proven to be critical players in the initial pathogenesis of prion disease, and may have a role in the pathological progression of disease. Understanding how prions interact with the host innate immune system may provide us with natural pathways and mechanisms to combat these diseases prior to their neuroinvasive stage. We present here a review of the current knowledge regarding the role of the innate immune system in prion pathogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, Y., Szretter, K. J., Vermi, W., Gilfillan, S., Rossini, C., Cella, M., Barrow, A. D., Diamond, M. S., & Colonna, M. (2012) · Nature Immunology · doi:10.1038/ni.2360 · Cited by 1,011 · cited 1×
“population of the CNS appears to require both CSF-1R ligands; interleukin-34 (Il-34) [93] and CSF-1 [94].”
BackgroundErblich, B., Zhu, L., Etgen, A. M., Dobrenis, K., & Pollard, J. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026317 · Cited by 649
A systems approach to prion disease
Hwang, D., Lee, I. Y., Yoo, H., Gehlenborg, N., Cho, J., Petritis, B., Baxter, D., Pitstick, R., Young, R., Spicer, D., et al. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.10 · Cited by 287 · cited 8×
“Complement C2 C2 P21180 E [44] Complement C3 C3 / HSE-MSF P01027 M [44,45,100,101]”
BackgroundInfluentialSaba, R., Gushue, S., Huzarewich, R. L. C. H., Manguiat, K., Medina, S., Robertson, C., & Booth, S. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030832 · Cited by 151 · cited 2×
“MicroRNA 146a miR-146a E [139] Monocyte differentiation antigen CD14 Cd14 P10810 E [101,106,115] Myeloid cell surface antigen CD33 Cd33 / Siglec3 Q63994 M [98] Myeloid differentiation primary response protein MyD88 Myd88 P22366 [69]”
BackgroundGene expression profiling of scrapie-infected brain tissue
Riemer, C., Neidhold, S., Burwinkel, M., Schwarz, A., Schultz, J., Krätzschmar, J., Mönning, U., & Baier, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.124 · Cited by 108 · cited 8×
“C–C motif chemokine 2 Ccl2 / MCP-1 P10148 E [105–107] C–C motif chemokine 3 Ccl3 / MIP-1α P10855 E [100,105,106] C–C motif chemokine 4 Ccl4 / MIP-1β P14097 E [106] C–C motif chemokine 5 Ccl5 / RANTES P30882 M [105] C–C motif chemokine 7 Ccl7 / MCP-3 Q03366 M [103] C–C motif chemokine 9 Ccl9 / MRP-2 P51670 M [99,102] C…”
BackgroundInfluentialPrion pathogenesis in the absence of Toll-like receptor signalling
Prinz, M., Heikenwalder, M., Schwarz, P., Takeda, K., Akira, S., & Aguzzi, A. (2003) · The EMBO Reports · doi:10.1038/sj.embor.embor731 · Cited by 85 · cited 3×
“MicroRNA 146a miR-146a E [139] Monocyte differentiation antigen CD14 Cd14 P10810 E [101,106,115] Myeloid cell surface antigen CD33 Cd33 / Siglec3 Q63994 M [98] Myeloid differentiation primary response protein MyD88 Myd88 P22366 [69]”
BackgroundAccelerated Prion Replication in, but Prolonged Survival Times of, Prion-Infected CXCR3−/−Mice
Riemer, C., Schultz, J., Burwinkel, M., Schwarz, A., Mok, S. W. F., Gültner, S., Bamme, T., Norley, S., van Landeghem, F., Lu, B., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01371-08 · Cited by 45
Cited by
Inflammation in neurodegenerative diseases—An update
Amor, S., Peferoen, L. A. N., Vogel, D. Y. S., Breur, M., van der Valk, P., Baker, D., & van Noort, J. M. (2014) · Immunology · doi:10.1111/imm.12233 · Cited by 550
Prion Pathogenesis in the Absence of NLRP3/ASC Inflammasomes
Nuvolone, M., Sorce, S., Schwarz, P., & Aguzzi, A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0117208 · Cited by 39
Toll-like receptor 2 confers partial neuroprotection during prion disease
Carroll, J. A., Race, B., Williams, K., & Chesebro, B. (2018) · PLOS ONE · doi:10.1371/journal.pone.0208559 · Cited by 22
Metadata
- Authors
- Bradford, B., & Mabbott, N.
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2012-11-28
- Volume
- 4
- Issue
- 12
- Pages
- 3389-3419
- ISSN
- 1999-4915 (ISSN-L)
- OpenAlex
- W2073778449
- Cited by
- 50
- References
- 7
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.